10/5/2026
Psyence BioMed to manufacture ibogaine in Texas with Benuvia
Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.
Topic archive
4 stories
10/5/2026
Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.
10/5/2026
Agreement aims to produce pharmaceutical-grade ibogaine in Texas facility.
9/11/2026
Ibogaine offers a novel approach to opioid detox, but carries significant risks.
9/8/2026
Jonathan Dickinson's new book explores ibogaine's therapeutic potential amid rising U.S. policy focus.